ROSSARI BIOTECH LIMITED

BSE: ROSSARI543213ISIN INE02A801020

Commodities
Specialty Chemicals
BSE 1000

Share price

₹421.80+14.10 (+3.46%)

as of 4 Nov 2026

Prices adjusted for splits and bonuses; cash dividends excluded. Volume shows actual shares traded.

52W high: ₹650.90
52W low: ₹372.90
Off 52W high: -35.20%
1M return: -2.03%
3M return: -19.73%
6M return: -14.01%
1Y return: -35.08%
20D avg volume: 4,033
50 DMA: ₹440.99
200 DMA: ₹487.49

Key ratios Consolidated

Market cap: ₹2,337 Cr
Current price: ₹421.80
52W high / low: ₹650.90 / ₹372.90
Face value: ₹2.00
P/E: 15.30
P/B: 1.66
EPS (TTM): ₹27.57
Book value / share: ₹254.10
ROE: —
ROCE: 15.30%
Operating margin: —
Net margin: —
Debt / equity: 0.31
Net debt: ₹332.68 Cr
Interest cover: 8.03
Dividend yield: 0.12%
Dividend / share (TTM): ₹0.50
Payout: 1.81%
Cash conversion cycle: 97.2 days

Financials

Metric	Q2 FY27	Q1 FY27	Q4 FY26	Q3 FY26	Q2 FY26	Q1 FY26	Q4 FY25	Q3 FY25	Q2 FY25	Q1 FY25	Q4 FY24	Q3 FY24
Income statement
	697.56	697.20	684.86	581.68	586.11	543.72	579.56	512.73	498.35	489.65	472.71	463.77
	0.60	3.19	19.07	0.51	1.60	1.20	1.79	0.55	0.72	0.95	0.39	3.50
	698.16	700.39	703.93	582.19	587.71	544.92	581.35	513.28	499.07	490.60	473.11	467.27
	649.36	653.17	640.20	540.09	538.51	499.34	533.79	471.23	451.25	443.82	427.72	419.51
	475.64	514.68	444.47	417.60	407.21	334.40	369.77	321.48	324.36	284.03	303.94	291.00
	17.79	14.66	24.10	10.97	29.39	28.96	33.88	45.99	42.34	42.55	38.67	25.30
	43.62	44.04	39.23	40.26	37.80	37.47	35.49	35.69	32.56	28.58	25.04	26.04
	8.68	10.98	9.06	7.67	6.09	5.73	5.50	4.94	3.68	3.69	2.52	4.32
	30.10	25.61	23.53	19.61	18.23	17.75	18.22	18.32	15.16	15.37	16.07	15.09
	89.66	81.71	72.66	71.75	75.53	67.05	72.93	62.23	59.14	55.28	45.81	51.08
	48.80	47.22	63.73	42.10	49.20	45.58	47.56	42.05	47.82	46.78	45.38	47.76
	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
	48.80	47.22	63.73	42.10	49.20	45.58	47.56	42.05	47.82	46.78	45.38	47.76
	10.36	12.58	18.28	9.73	12.80	12.50	13.26	10.68	12.78	12.09	11.44	13.39
	38.91	35.09	45.97	32.77	36.88	33.60	34.44	31.70	35.33	34.90	34.13	34.39
	7.02	6.34	8.30	5.92	6.66	6.07	6.22	5.73	6.39	6.32	6.18	6.23
Key metrics
	87.58	83.81	96.32	69.38	73.52	69.06	71.28	65.31	66.66	65.84	63.97	67.17
	12.60%	12.00%	14.10%	11.90%	12.50%	12.70%	12.30%	12.70%	13.40%	13.40%	13.50%	14.50%
	5.60%	5.00%	6.70%	5.60%	6.30%	6.20%	5.90%	6.20%	7.10%	7.10%	7.20%	7.40%
	3.70%	—	4.90%	—	3.80%	—	3.90%	—	—	—	—	—
	19.00%	28.20%	18.20%	13.40%	17.60%	11.00%	22.60%	10.60%	—	—	—	—
	5.50%	4.40%	33.50%	3.40%	4.40%	-3.70%	0.90%	-7.80%	—	—	—	—

Metric	TTM	FY26	FY25	FY24	FY23	FY22
Income statement
	2,661	2,396	2,080	1,831	1,656	1,483
	23.37	22.38	4.01	7.45	5.48	12.00
	2,685	2,419	2,084	1,838	1,661	1,495
	2,483	2,218	1,900	1,661	1,518	1,360
	1,852	1,604	1,300	1,230	1,079	970.12
	67.52	93.42	164.77	127.13	104.85	155.21
	167.15	154.75	132.33	103.13	98.62	67.93
	36.39	28.54	17.81	19.37	22.32	12.66
	98.85	79.12	67.07	60.39	62.93	48.05
	315.78	286.99	249.59	184.15	162.93	126.56
	201.85	200.61	184.21	177.44	143.26	134.73
	0.00	0.00	0.00	0.00	0.00	0.00
	201.85	200.61	184.21	177.44	143.26	134.73
	50.95	53.30	48.81	46.93	36.96	38.58
	152.74	149.21	136.38	130.69	107.26	97.69
	27.58	26.95	24.66	23.67	19.46	17.81
Key metrics
	337.09	308.27	269.09	257.20	228.51	195.44
	12.67%	12.90%	12.90%	14.10%	13.80%	13.20%
	5.74%	6.20%	6.60%	7.10%	6.50%	6.60%
	—	15.30%	14.90%	—	—	—
	19.76%	15.20%	13.60%	10.50%	11.70%	—
	11.80%	9.40%	4.40%	21.80%	9.80%	—
	—	-199.60	-21.07	—	—	—
	—	0.44	1.01	—	—	—
	—	0.31	0.16	—	—	—
	—	332.68	143.77	—	—	—
	—	97.2	95.4	—	—	—
Balance sheet
	—	2,289	1,896	—	—	—
	—	1,236	1,042	—	—	—
	—	75.31	44.20	—	—	—
	—	557.41	474.50	—	—	—
	—	404.55	355.08	—	—	—
	—	139.56	93.39	—	—	—
	—	560.54	353.53	—	—	—
	—	323.45	286.33	—	—	—
	—	789.56	536.57	—	—	—
	—	407.99	187.97	—	—	—
	—	313.66	87.94	—	—	—
	—	94.33	100.03	—	—	—
	—	1,333	1,185	—	—	—
Cash flow
	—	65.07	137.44	—	—	—
	—	-219.48	-183.69	—	—	—
	—	186.32	64.90	—	—	—
	—	264.67	158.51	—	—	—

Metric	Q2 FY27	Q1 FY27	Q4 FY26	Q3 FY26	Q2 FY26	Q1 FY26	Q4 FY25	Q3 FY25	Q2 FY25	Q1 FY25	Q4 FY24	Q3 FY24
Income statement
	495.28	482.27	516.14	450.66	419.51	365.76	426.65	368.28	335.99	300.71	313.80	298.75
	1.69	2.19	22.73	1.14	1.40	1.74	2.40	1.01	1.08	1.26	1.34	2.13
	496.96	484.46	538.87	451.80	420.91	367.50	429.05	369.28	337.07	301.97	315.15	300.88
	450.81	438.04	465.32	411.70	378.94	332.06	385.19	328.02	300.16	269.30	280.40	266.08
	314.54	294.39	328.89	274.93	250.87	211.74	258.67	209.81	212.66	129.98	167.53	150.93
	78.50	75.55	58.04	58.55	71.79	50.08	61.82	57.74	49.40	84.04	69.89	54.30
	20.88	20.39	17.75	18.73	17.31	15.67	15.76	16.36	13.56	14.32	11.38	14.06
	2.08	3.84	3.81	3.95	2.49	3.09	3.08	2.28	1.90	2.33	1.74	2.63
	10.73	8.34	8.97	7.47	7.34	7.15	7.66	7.43	6.54	6.06	6.58	5.84
	45.51	49.27	43.60	45.53	43.34	34.98	42.88	35.72	31.60	28.11	20.83	27.23
	46.15	46.42	73.55	40.10	41.97	35.44	43.86	41.26	36.91	32.67	34.74	34.80
	0.00	0.00	0.00	0.00	0.00	0.00	0.00	—	—	—	—	—
	46.15	46.42	73.55	40.10	41.97	35.44	43.86	41.26	36.91	32.67	34.74	34.80
	11.92	12.15	18.82	9.47	10.72	9.21	11.49	10.63	9.49	8.34	8.58	9.26
	34.23	34.27	54.73	30.63	31.25	26.23	32.36	30.63	27.42	24.33	26.17	25.54
	6.18	6.19	9.88	5.53	5.64	4.74	5.85	5.53	4.96	4.40	4.74	4.62
Key metrics
	58.96	58.60	86.33	51.52	51.80	45.68	54.60	50.97	45.35	41.06	43.06	43.27
	11.90%	12.20%	16.70%	11.40%	12.30%	12.50%	12.80%	13.80%	13.50%	13.70%	13.70%	14.50%
	6.90%	7.10%	10.60%	6.80%	7.40%	7.20%	7.60%	8.30%	8.20%	8.10%	8.30%	8.50%
	3.70%	—	6.20%	—	3.90%	—	4.30%	—	—	—	—	—
	18.10%	31.90%	21.00%	22.40%	24.90%	21.60%	36.00%	23.30%	—	—	—	—
	9.50%	30.70%	69.10%	0.00%	14.00%	7.80%	23.70%	19.90%	—	—	—	—

Metric	TTM	FY26	FY25	FY24	FY23	FY22
Income statement
	1,944	1,752	1,432	1,203	975.17	1,073
	27.75	27.01	5.74	6.77	3.60	12.70
	1,972	1,779	1,437	1,210	978.77	1,086
	1,766	1,588	1,283	1,076	883.12	978.86
	1,213	1,066	811.12	625.73	553.96	707.98
	270.64	238.46	253.00	284.99	163.33	122.29
	77.75	69.46	60.01	51.46	57.35	43.53
	13.68	13.35	9.58	9.70	4.62	2.54
	35.51	30.93	27.69	24.19	25.98	26.27
	183.91	167.45	138.31	93.05	90.86	86.59
	206.22	191.06	154.70	134.13	95.64	106.68
	0.00	0.00	0.00	—	—	—
	206.22	191.06	154.70	134.13	95.64	106.68
	52.36	48.22	39.96	34.49	24.25	27.21
	153.86	142.84	114.74	99.64	71.39	79.47
	27.78	25.79	20.75	18.05	12.95	14.49
Key metrics
	255.41	235.34	191.97	168.02	126.24	135.49
	13.14%	13.40%	13.40%	14.00%	12.90%	12.60%
	7.91%	8.20%	8.00%	8.30%	7.30%	7.40%
	—	16.50%	15.00%	—	—	—
	23.04%	22.40%	19.00%	23.40%	-9.10%	—
	27.72%	24.50%	15.20%	39.60%	-10.20%	—
	—	-60.01	39.23	—	—	—
	—	0.41	0.80	—	—	—
	—	0.10	0.03	—	—	—
	—	77.86	17.23	—	—	—
	—	69.0	68.2	—	—	—
Balance sheet
	—	1,764	1,451	—	—	—
	—	903.00	696.95	—	—	—
	—	48.65	12.91	—	—	—
	—	518.43	374.60	—	—	—
	—	179.73	178.83	—	—	—
	—	39.79	39.07	—	—	—
	—	211.17	170.99	—	—	—
	—	366.82	285.93	—	—	—
	—	521.19	354.32	—	—	—
	—	126.51	30.14	—	—	—
	—	121.39	30.14	—	—	—
	—	5.12	0.00	—	—	—
	—	1,218	1,077	—	—	—
Cash flow
	—	58.73	92.20	—	—	—
	—	-101.40	-69.92	—	—	—
	—	79.13	-32.27	—	—	—
	—	118.74	52.97	—	—	—

Compounded growth

Standalone

Sales CAGR 3Y: +21.57%
Sales CAGR 5Y: —
Profit CAGR 3Y: +26.01%
Profit CAGR 5Y: —
Sales YoY (TTM): +23.04%
Profit YoY (TTM): +27.72%

Consolidated

Sales CAGR 3Y: +13.11%
Sales CAGR 5Y: —
Profit CAGR 3Y: +11.63%
Profit CAGR 5Y: —
Sales YoY (TTM): +19.76%
Profit YoY (TTM): +11.80%

Compounded from reported annual figures. We publish no share-price CAGR: our prices are as-traded, so one would be wrong across every split and bonus issue.

Shareholding as of 30 Sep 2026

Promoter holding: 68.13%

Quarter	September 2026	June 2026
Promoter %	68.13%	68.15%

Holder	Type	Holding	Previous	Change
Edward Menezes	Promoter	29.10%	29.10%	0.00%
SUNIL SRINIVASAN CHARI	Promoter	13.16%	13.16%	0.00%
Chari Family Trust in the name of Sunil Srinivasan Chari and Jyotishna Sunil Chari	Promoter Group	9.22%	9.23%	-0.01%
Uti Aggressive Hybrid Fund	Public	6.36%	—	—
Rossari Biotech India Private Limited	Promoter Group	5.44%	5.45%	-0.01%
Jyotishna Sunil Chari	Promoter Group	4.51%	4.51%	0.00%
YASH SUNIL CHARI	Promoter Group	4.45%	4.45%	0.00%
Life Insurance Corporation of India	Public	4.01%	4.01%	0.00%
Canara Robeco Mutual Fund A/C Canara Robeco Small Cap Fund	Public	1.85%	1.90%	-0.05%
ANITA MENEZES	Promoter Group	1.81%	1.81%	0.00%
Bhupesh Kumar Lodha	Public	1.08%	—	—
MIKHAIL MENEZES	Promoter Group	0.24%	0.24%	0.00%
Menezes Family Trust in the name of Edward Walter Menezes and Anita Menezes	Promoter Group	0.20%	0.20%	0.00%
Priya Shivdasani	Promoter Group	0.00%	0.00%	0.00%
Yvette Santhmayor	Promoter Group	0.00%	0.00%	0.00%

Public shareholders are disclosed individually only above 1%.

Peer comparison

Company	Mkt cap (₹ Cr)	Price (₹)	P/E	ROCE	Sales YoY	Profit YoY	1Y return
Pidilite Industries Ltd.	1,53,494	1,507.00	56.47	28.50%	+16.83% TTM	+20.94% TTM	+3.57%
Gujarat Fluorochemicals Limited	50,673	4,612.90	75.63	10.10%	+20.33% TTM	-1.47% TTM	+25.63%
Navin Fluorine International Limited	45,075	8,785.00	49.50	18.70%	+45.68% TTM	+105.04% TTM	+45.12%
Deepak Nitrite Limited	21,559	1,580.65	20.29	10.80%	+23.80% TTM	+99.83% TTM	-9.73%
Aether Industries Limited	20,478	1,542.85	82.16	12.20%	+30.76% TTM	+28.03% TTM	+103.85%
Aarti Industries Ltd	16,311	449.65	27.46	8.50%	+39.85% TTM	+104.40% TTM	+16.66%
Fine Organic Industries Limited	15,720	5,127.35	38.71	20.20%	+12.92% TTM	+18.80% TTM	+16.19%
Atul Limited.	15,177	5,155.00	19.28	13.50%	+18.15% TTM	+40.10% TTM	-12.49%
Anupam Rasayan India Limited	13,029	1,144.40	57.92	7.50%	+51.76% TTM	+14.65% TTM	+6.58%
PRIVI SPECIALITY CHEMICALS LIMITED	12,825	3,283.30	34.73	25.10%	+17.54% TTM	+44.15% TTM	+10.09%
BASF India Ltd	12,812	2,959.95	21.44	13.10%	+13.35% TTM	+59.30% TTM	-33.46%
Sudeep Pharma Limited	12,657	1,120.60	67.10	24.20%	—	—	—
Vinati Organics Ltd.	10,334	996.85	25.09	17.70%	+10.98% TTM	-5.48% TTM	-39.90%
Elantas Beck India Ltd S	10,127	12,774.65	54.20	—	+18.86% TTM	+35.25% TTM	+29.29%
Jubilant Ingrevia Limited	8,957	562.35	25.55	10.80%	+15.41% TTM	+21.73% TTM	-18.43%
Alkyl Amines Chemicals Ltd. S	8,108	1,585.25	32.77	14.60%	+13.38% TTM	+35.83% TTM	-13.31%
Galaxy Surfactants Limited	8,048	2,269.80	22.75	12.70%	+27.05% TTM	+16.13% TTM	+0.01%
Clean Science and Technology Limited	6,979	656.60	29.92	19.20%	+4.51% TTM	-12.06% TTM	-33.34%
Neogen Chemicals Limited	6,815	2,268.40	168.60	6.80%	+26.66% TTM	+55.16% TTM	+54.05%
Fineotex Chemical Limited	6,221	53.42	41.98	16.20%	+91.44% TTM	+41.07% TTM	+84.27%
Balaji Amines Ltd.	5,738	1,770.80	23.80	10.20%	+20.91% TTM	+66.05% TTM	+26.00%
Archean Chemical Industries Limited	5,291	428.60	54.04	7.80%	+5.99% TTM	-42.66% TTM	-34.05%
Prasol Chemicals Limited	4,594	776.20	—	—	—	—	—
Laxmi Organic Industries Limited	4,501	161.95	35.81	4.40%	+5.47% TTM	+25.01% TTM	-17.12%
Foseco India Ltd S	4,494	5,962.25	57.00	—	+10.33% TTM	-3.71% TTM	+5.42%
ROSSARI BIOTECH LIMITED	2,337	421.80	15.30	15.30%	+19.76% TTM	+11.80% TTM	-35.08%

Some figures use IPO-document inputs. Growth periods are shown per value; FY means annual.

Filings & corporate actions

Recent announcements

Intimation of Transcript of Q2 & H1 FY27 for the Earnings Conference Call held on October 19, 202622 Oct 2026 · Company Update / Earnings Call Transcript
Audio recording of Earnings Conference Call for Q2 & H1 FY 27.19 Oct 2026 · Company Update / Analyst / Investor Meet
Press Release for Q2 FY27 Results19 Oct 2026 · Company Update / Press Release / Media Release
Intimation of Q2 & H1 FY27- Earnings Presentation19 Oct 2026 · Company Update / Investor Presentation
Newspaper publication of extract of Consolidated Unaudited Financial Results for the quarter and half year ended September 30, 2026.18 Oct 2026 · Company Update / Newspaper Publication
Unaudited Financial Results (Standalone and Consolidated) for the Quarter and Half year ended September 30, 2026.17 Oct 2026 · Result / Financial Results
Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 201517 Oct 2026 · Company Update / General
Outcome of Board Meeting Held On October 17, 202617 Oct 2026 · Board Meeting / Outcome of Board Meeting
Intimation of Earnings Conference Call for investor and analyst on Monday, October 19, 2026 at 04:00 P.M. (IST).14 Oct 2026 · Company Update / Analyst / Investor Meet
Rossari Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 17/10/2026 ,inter alia, to consider and approve Unaudited Financial Results ....9 Oct 2026 · Board Meeting / Board Meeting
Compliance Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 20266 Oct 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Rossari Biotech Limited has informed the Exchange regarding the Trading Window Closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015.25 Sep 2026 · Insider Trading / SAST / Closure of Trading Window
Intimation of Analyst/ Institutional Investor Meet/ Con. Call/Updates.16 Sep 2026 · Company Update / Analyst / Investor Meet
Intimation of Analyst/Institutional Investors Meet/Con. Call/Updates.10 Sep 2026 · Company Update / Analyst / Investor Meet
Intimation of non-participation in the investors and analysts meet scheduled on Monday, August 10, 2026.6 Aug 2026 · Company Update / General
Intimation of Analyst/ Institutional Investor Meet/ Con. Call/Updates.3 Aug 2026 · Company Update / Analyst / Investor Meet
Intimation of Transcript of Q1 FY 27 for the Earnings Conference Call held on July 20, 2026.24 Jul 2026 · Company Update / Earnings Call Transcript
Scrutinizer''s Report for the 17th Annual General Meeting of the Members of the Company.20 Jul 2026 · AGM/EGM / AGM
Outcome of 17th Annual General Meeting of the Members of the Company along with Proceedings, Voting Results and Scrutinizers Report.20 Jul 2026 · AGM/EGM / AGM
Audio recording of Earnings Conference Call for Q1 FY 27.20 Jul 2026 · Company Update / Analyst / Investor Meet
Update on Grant of Options.20 Jul 2026 · Company Update / General
Rossari Biotech Limited informed the Exchange regarding Press Release dated July 18, 2026 titled " Rossari Biotech Limited announces Q1 FY 27 results".19 Jul 2026 · Company Update / Press Release / Media Release
Intimation of Q1 FY27- Earnings Presentation.19 Jul 2026 · Company Update / Investor Presentation
Newspaper publication of extract of Consolidated Unaudited Financial Results for the quarter ended June 30, 2026.19 Jul 2026 · Company Update / Newspaper Publication
Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 201518 Jul 2026 · Company Update / General
Intimation of grant of 4000 options Under Rossari Employee Stock Option Plan - 201918 Jul 2026 · Company Update / General
Intimation of allotment of 2500 Equity Shares under Rossari Employee Stock Option Plan - 201918 Jul 2026 · Company Update / Allotment of ESOP / ESPS
Unaudited Financial Results (standalone and consolidated) for the quarter ended June 30, 202618 Jul 2026 · Result / Financial Results
Board Meeting held on Saturday, July 18, 202618 Jul 2026 · Board Meeting / Outcome of Board Meeting
Intimation of Earnings Conference Call for investor and analyst on Monday, July 20, 2026 at 05:00 P.M. (IST).14 Jul 2026 · Company Update / Analyst / Investor Meet
Rossari Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 18/07/2026 ,inter alia, to consider and approve Unaudited Financial Results ....10 Jul 2026 · Board Meeting / Board Meeting
Compliance Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended June 30, 20267 Jul 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Newspaper Publication of Notice of 17th Annual General Meeting of the Company and details relating to E-voting facility28 Jun 2026 · Company Update / Newspaper Publication
Intimation regarding dispatch of letters to non-email shareholders.27 Jun 2026 · Company Update / General
Business Responsibility and Sustainability Report for the Financial Year 2025-26.27 Jun 2026 · Others / Business Responsibility and Sustainability Reporting (BRSR)
Intimation of 17th Annual General Meeting ("AGM") of the Company to be held on Monday, July 20, 2026 at 11:00 A.M. (IST) through Video Conferencing/ Other Audio Visual Means ("VC/OAVM").27 Jun 2026 · AGM/EGM / AGM
Annual Report for the Financial Year 2025-26.27 Jun 2026 · Others / Reg. 34 (1) Annual Report
Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.26 Jun 2026 · Company Update / General
Rossari Biotech Limited has informed the Exchange regarding the Trading Window Closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015.25 Jun 2026 · Insider Trading / SAST / Closure of Trading Window
Newspaper publication of Notice of information regarding the 17th Annual General Meeting of the Company scheduled to be held on Monday, July 20, 2026.19 Jun 2026 · Company Update / Newspaper Publication

Corporate actions

Purpose	Ex date	Record date	Payment date
Final Dividend - Rs. - 0.5000	10 Jul 2026	10 Jul 2026	—
Final Dividend - Rs. - 0.5000	20 Jun 2025	20 Jun 2025	—
E.G.M.	4 Nov 2024	—	—
Final Dividend - Rs. - 0.5000	16 Aug 2024	—	—

Board meetings

17 Oct 2026 Board Meeting - Financial Results
18 Jul 2026 Board Meeting - Financial Results